Rybelsus 14mg Tablet

Rybelsus 14mg tablet contains semaglutide as its active component. It belongs to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This medication is used to treat type 2 diabetes by lowering blood sugar levels and promoting weight loss. It also reduces the risk of cardiovascular events in patients with high-risk diabetes. It can be combined with other diabetes medications to achieve better glycaemic control and may lower blood pressure, with potential benefits for cardiovascular health. Additionally, it shows potential in protecting kidney function and slowing the progression of diabetic kidney disease.

Rybelsus 14mg tablet should not be taken if you have known hypersensitivity to semaglutide or any of its components. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take this medication. It is not approved for use in paediatric patients with type 2 diabetes. It should not be used in individuals with a history of severe gastrointestinal disease, such as gastroparesis. This medication is not recommended for patients with severe renal impairment or end-stage renal disease.

rybelsus 14 mg uses to treat the following: Type 2 diabetes mellitus Obesity or overweight.

Rybelsus 14mg tablet, a GLP-1 receptor agonist, exerts its therapeutic effects by mimicking the action of the naturally occurring hormone GLP-1. In diabetes management, this medication enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production. This medication effect leads to improved glycemic control and reduced HbA1c levels. Additionally, this medication promotes weight loss through increased satiety, decreased food intake, and modulation of gastric function. It has also demonstrated cardiovascular benefits, including a potential reduction in major cardiovascular events.

Rybelsus 14mg tablet is typically administered as a subcutaneous injection. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any necessary adjustments to your treatment plan.

rybelsus 14 mg side effects like all medications, although not everyone will experience them. Serious Allergic reactions Pancreatitis (abdominal pain, nausea, vomiting) Hypoglycemia (low blood sugar) Kidney problems (changes in urination, swelling in the ankles or feet) Thyroid C-cell tumors Common Nausea Vomiting Diarrhea Constipation Abdominal pain Decreased appetite Headache Fatigue Injection site reactions (e.g., redness, pain, itching)